Biotech

All Articles

Arch shuts $3B-plus fund to cultivate biopharma startups

.On the heels of a $3 billion fund from Bain Financing Life Sciences, Arch Endeavor Partners is veri...

Orion to use Aitia's 'electronic identical twins' to locate brand new cancer cells medicines

.Finnish biotech Orion has spied prospective in Aitia's "electronic twin" technology to build new ca...

Windtree's surprise med raises blood pressure in most recent phase 2 succeed

.While Windtree Rehabs has actually struggled to grow the economic origins needed to have to make it...

2 cancer cells biotechs merge, making worldwide impact

.OncoC4 is taking AcroImmune-- as well as its own internal scientific manufacturing functionalities-...

Amgen reports initial phase 3 win for $400M chronic eczema medication

.Amgen has actually discussed (PDF) the very first phase 3 records on its own $400 million chronic e...

Biogen, UCB report period 3 lupus succeed after stopping working earlier test

.Biogen and UCB's depend developing in to stage 3 astride a broken study looks to have actually paid...

Aptadir hopes new RNA preventions may reverse tricky cancers

.Italian biotech Aptadir Therapies has actually launched along with the promise that its own pipe of...

Wave surfs DMD effectiveness to regulators' doors, sending stock up

.Wave Life Sciences has met its own target in a Duchenne muscle dystrophy (DMD) study, positioning i...

Sanofi tweezes brand new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer, occup...

Achilles droplets cell treatment course, prepares for discharges after skipping 'office feasibility' goals

.Achilles Therapeutics has actually destroyed its strategy. The English biotech is actually quiting ...